Combining Intermittent Fasting With Microplastic Exposure Worsens Gut Inflammation, Mouse Study Finds

Intermittent fasting has earned a strong reputation as a tool for reducing inflammation and supporting gut health. But a new mouse study published in June 2026 in npj Biofilms and Microbiomes adds a significant caveat: when microplastic exposure enters the picture, fasting may amplify gut damage rather than blunt it. The findings are early and preliminary, but they point toward a previously unrecognized interaction between two increasingly common features of modern life.

Intermittent Fasting Amplified Polystyrene Microplastic Gut Damage

Researchers led by Rui Fu and colleagues gave mice chronic oral exposure to 1 micrometer polystyrene microplastics over six weeks, pairing that exposure with a time-restricted feeding window of eight hours per day, the standard model for intermittent fasting. Mice in the combined microplastic-plus-fasting group fared measurably worse than those exposed to microplastics alone. They showed lower body weight, more pronounced colon shortening, higher levels of the pro-inflammatory cytokines TNF-alpha and IL-1 beta, and a drop in the anti-inflammatory signal IL-10. Oxidative stress markers including malondialdehyde and oxidized glutathione rose, while reduced glutathione fell. The colon tissue of these animals showed clear signs of mucosal injury that were not present to the same degree in mice eating without time restrictions.

Microplastics are synthetic polymer particles smaller than 5 millimeters, present in food, drinking water, and household dust. Research has linked microplastic accumulation in the gut to dysbiosis, impaired barrier function, and systemic inflammation, though human epidemiological data remain limited. What this study adds is the suggestion that a popular dietary intervention, one often prescribed specifically for its anti-inflammatory properties, can reverse course when a gut already under environmental stress.

Rikenella Depletion Sits at the Center of the Harm

16S rRNA sequencing of the gut microbiome revealed that the combined exposure sharply depleted several beneficial bacterial taxa, including Muribaculaceae, Lachnospiraceae, and notably Rikenella. The loss of Rikenella appeared to be functionally important. When the team cleared the gut microbiome with antibiotics and then reintroduced Rikenella by supplementation, animals recovered measurable ground: body weight increased, colon length improved, inflammatory cell infiltration dropped, and the cytokine profile shifted toward anti-inflammatory. Transcriptomic analysis showed that Rikenella supplementation downregulated pro-inflammatory genes including Il17a and Il21, both linked to the Th17 immune pathway.

The gut microbiome plays a central role in calibrating the balance between Th17 and regulatory T cells, a balance that governs both intestinal and systemic immune tone. Gut bacteria help maintain the Th17 and Treg equilibrium that keeps inflammation from running unchecked. In the microplastic-plus-fasting mice, that equilibrium broke down: multiplex immunofluorescence and flow cytometry confirmed more Th17 cells and fewer Treg cells, producing an elevated Th17/Treg ratio consistent with a pro-inflammatory shift.

Disrupted Purine Metabolism Links the Microbiome to Immune Dysregulation

The team then used untargeted metabolomics to ask what molecular signals might connect Rikenella loss to immune dysregulation. Purine metabolism emerged as the most significantly disrupted pathway in the microplastic-plus-fasting group, with reduced levels of xanthine and hypoxanthine standing out in particular. Hypoxanthine levels correlated positively with Rikenella abundance, and culture supernatant from Rikenella itself contained detectable hypoxanthine, suggesting the bacterium contributes directly to local hypoxanthine availability in the colon.

To test whether this metabolite was driving the immune effects, researchers supplemented mice with hypoxanthine directly. The result closely mirrored Rikenella supplementation: Th17 cells decreased, Treg cells increased, and the Th17/Treg ratio improved. This microbiota-metabolite-immune axis, running from Rikenella through hypoxanthine to T cell balance, offers a mechanistic thread that future work can pull on. Single-cell transcriptomics of intestinal tissue from MP-treated mice also showed enrichment of the Th17 differentiation program and enhanced ICAM signaling among T helper cells, pointing to coordinated immune activation across cell populations.

Caveats: Mouse Model, Open Mechanism, and Uncertain Human Translation

The study has important limitations that the authors acknowledge. It was conducted entirely in mice, and while rodent models are standard for early mechanistic work, findings may not translate directly to humans. Critically, the causal direction between microplastic exposure and intermittent fasting in driving injury is not fully resolved: the study establishes that the combination is worse, but not precisely which factor initiates the cascade or whether one dominates the other.

Significant gaps remain in understanding how microplastic exposure affects human health, including the absence of standardized methods for quantifying microplastics in biological tissues and a shortage of long-term epidemiological data. The dose of polystyrene microplastics used in this study, while grounded in experimental convention, may not reflect typical human exposure. Intermittent fasting has shown benefits for gut inflammation in other animal models, so the adverse interaction observed here appears context-dependent rather than a general indictment of the dietary pattern.

What Comes Next for Microbiome-Targeted Gut Protection

The researchers call for future work to define the specific conditions under which intermittent fasting shifts from beneficial to harmful, particularly for people with high environmental pollutant exposure. The Rikenella-hypoxanthine axis represents a potential therapeutic target: if the mechanism holds in humans, probiotic or metabolite-based strategies aimed at restoring hypoxanthine availability could theoretically protect against microplastic-related gut inflammation. That remains speculative for now.

For the millions of people practicing intermittent fasting while living in environments with unavoidable microplastic exposure, which is to say essentially everyone, the study raises a question worth tracking as the evidence matures. It does not counsel abandoning time-restricted eating. What it does suggest is that the immunomodulatory effects of fasting are not universal goods: they appear to depend on what else the gut is dealing with at the same time.

Evidence rating

INVESTIGATIONAL — 78/100

Caveats:

• This study was conducted entirely in mice; whether intermittent fasting poses the same risk to humans exposed to microplastics is unknown.
• Funding was not disclosed by the authors, so independent verification of the research context cannot be confirmed.
• The study cannot establish which factor — microplastic exposure or intermittent fasting — is the primary driver of harm, as the directional relationship was not resolved.
• Findings have not yet been independently replicated.

Murine study using chronic oral polystyrene microplastic exposure combined with time-restricted feeding (n = animal groups only; no human subjects). The multi-omics design — 16S sequencing, untargeted metabolomics, flow cytometry, and rescue supplementation experiments — supports a mechanistic chain rather than mere association, but all findings are preclinical and have not been replicated in an independent cohort. Funding was not disclosed by the authors.

References

1. Rui Fu, Yixian Cheng, Junjie Chen, et al. (2026). Intermittent fasting exacerbates microplastic-induced gut inflammation via Rikenella-mediated regulation of purine metabolism and Th17/Treg balance. npj Biofilms and Microbiomes. https://doi.org/10.1038/s41522-026-01016-5
2. Sudipta Sankar Bora, Rahul Gogoi, Madhurjya Ranjan Sharma, et al. (2024). Microplastics and human health: unveiling the gut microbiome disruption and chronic disease risks. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2024.1492759
3. Jing Wang, Yaqin Hou, Lifeng Mu, Ming Yang, Xiaopeng Ai (2024). Gut microbiota contributes to the intestinal and extraintestinal immune homeostasis by balancing Th17/Treg cells. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2024.113570
4. Hong Giang Hoang, Ngoc Son Hai Nguyen, Tao Zhang, Huu-Tuan Tran, Santanu Mukherjee, Ravi Naidu (2025). A review of microplastic pollution and human health risk assessment: current knowledge and future outlook. Frontiers in Environmental Science. https://doi.org/10.3389/fenvs.2025.1606332
5. Eva Haasis, Anna Bettenburg, Axel Lorentz (2024). Effect of Intermittent Fasting on Immune Parameters and Intestinal Inflammation. Nutrients. https://doi.org/10.3390/nu16223956